Publication | Closed Access

The 4′-O-benzylated doxorubicin analog WP744 overcomes resistance mediated by P-glycoprotein, multidrug resistance protein and breast cancer resistance protein in cell lines and acute myeloid leukemia cells

Health SciencesMedicineCell LinesCancer BiologyAnti-cancer AgentPharmacologyRadiation OncologyMultidrug Resistance ProteinDrug Resistance